The study database in Reference [28] was used to analyze the survival rate in breast cancer patients who expressed low/high visfatin genes (217738_at) in which 869 patients with estrogen receptor (ER)-negative breast cancer were included. This evidence concerns the gene NAMPT and breast cancer.